These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20812851)

  • 1. Interferon γ responses to mycobacterial antigens protect against subsequent HIV-associated tuberculosis.
    Lahey T; Sheth S; Matee M; Arbeit R; Horsburgh CR; Mtei L; Mackenzie T; Bakari M; Vuola JM; Pallangyo K; von Reyn CF
    J Infect Dis; 2010 Oct; 202(8):1265-72. PubMed ID: 20812851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte proliferation to mycobacterial antigens is detectable across a spectrum of HIV-associated tuberculosis.
    Lahey T; Matee M; Mtei L; Bakari M; Pallangyo K; von Reyn CF
    BMC Infect Dis; 2009 Feb; 9():21. PubMed ID: 19236695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline mycobacterial immune responses in HIV-infected adults primed with bacille Calmette-Guérin during childhood and entering a tuberculosis booster vaccine trial.
    Matee M; Lahey T; Vuola JM; Mtei L; Cole BF; Bakari M; Arbeit RD; Horsburgh CR; Pallangyo K; von Reyn CF
    J Infect Dis; 2007 Jan; 195(1):118-23. PubMed ID: 17152015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyantigenic interferon-γ responses are associated with protection from TB among HIV-infected adults with childhood BCG immunization.
    Lahey T; Mitchell BK; Arbeit RD; Sheth S; Matee M; Horsburgh CR; MacKenzie T; Mtei L; Bakari M; Vuola JM; Pallangyo K; von Reyn CF
    PLoS One; 2011; 6(7):e22074. PubMed ID: 21799772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Greater preexisting interferon γ responses to mycobacterial antigens and lower bacillary load during HIV-associated tuberculosis.
    Lahey T; Czechura T; Crabtree S; Arbeit RD; Matee M; Horsburgh CR; MacKenzie T; Bakari M; Pallangyo K; von Reyn CF
    J Infect Dis; 2013 Nov; 208(10):1629-33. PubMed ID: 23908490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of an inactivated mycobacterial vaccine for the prevention of HIV-associated tuberculosis: a randomized, controlled trial.
    Vuola JM; Ristola MA; Cole B; Järviluoma A; Tvaroha S; Rönkkö T; Rautio O; Arbeit RD; von Reyn CF
    AIDS; 2003 Nov; 17(16):2351-5. PubMed ID: 14571187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of tuberculosis in Bacille Calmette-Guérin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine.
    von Reyn CF; Mtei L; Arbeit RD; Waddell R; Cole B; Mackenzie T; Matee M; Bakari M; Tvaroha S; Adams LV; Horsburgh CR; Pallangyo K;
    AIDS; 2010 Mar; 24(5):675-85. PubMed ID: 20118767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of a protective whole cell mycobacterial vaccine in HIV-infected adults: a phase III study in Tanzania.
    Lahey T; Arbeit RD; Bakari M; Horsburgh CR; Matee M; Waddell R; Mtei L; Vuola JM; Pallangyo K; von Reyn CF
    Vaccine; 2010 Nov; 28(48):7652-8. PubMed ID: 20875492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
    Badell E; Nicolle F; Clark S; Majlessi L; Boudou F; Martino A; Castello-Branco L; Leclerc C; Lewis DJ; Marsh PD; Gicquel B; Winter N
    Vaccine; 2009 Jan; 27(1):28-37. PubMed ID: 18977269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gamma interferon responses induced by a panel of recombinant and purified mycobacterial antigens in healthy, non-mycobacterium bovis BCG-vaccinated Malawian young adults.
    Black GF; Weir RE; Chaguluka SD; Warndorff D; Crampin AC; Mwaungulu L; Sichali L; Floyd S; Bliss L; Jarman E; Donovan L; Andersen P; Britton W; Hewinson G; Huygen K; Paulsen J; Singh M; Prestidge R; Fine PE; Dockrell HM
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):602-11. PubMed ID: 12853392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety and immunogenicity of an adenovirus type 35-vectored TB vaccine in HIV-infected, BCG-vaccinated adults with CD4(+) T cell counts >350 cells/mm(3).
    Churchyard GJ; Snowden MA; Hokey D; Dheenadhayalan V; McClain JB; Douoguih M; Pau MG; Sadoff J; Landry B
    Vaccine; 2015 Apr; 33(15):1890-6. PubMed ID: 25698492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and immunogenicity of recombinant Mycobacterium bovis Bacillus Calmette-Guérin strains secreting the antigen ESAT-6 from Mycobacterium tuberculosis in mice.
    Wang LM; Shi CH; Fan XL; Xue Y; Bai YL; Xu ZK
    Chin Med J (Engl); 2007 Jul; 120(14):1220-5. PubMed ID: 17697571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterial T cell responses in HIV-infected patients with advanced immunosuppression.
    Hammond AS; McConkey SJ; Hill PC; Crozier S; Klein MR; Adegbola RA; Rowland-Jones S; Brookes RH; Whittle H; Jaye A
    J Infect Dis; 2008 Jan; 197(2):295-9. PubMed ID: 18194089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-sensitive and rapid detection of Mycobacterium tuberculosis infection by IFN-gamma release assay among HIV-infected individuals in BCG-vaccinated area.
    Jiang W; Shao L; Zhang Y; Zhang S; Meng C; Xu Y; Huang L; Wang Y; Wang Y; Weng X; Zhang W
    BMC Immunol; 2009 May; 10():31. PubMed ID: 19476627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculin-purified protein derivative-, MPT-64-, and ESAT-6-stimulated gamma interferon responses in medical students before and after Mycobacterium bovis BCG vaccination and in patients with tuberculosis.
    Johnson PD; Stuart RL; Grayson ML; Olden D; Clancy A; Ravn P; Andersen P; Britton WJ; Rothel JS
    Clin Diagn Lab Immunol; 1999 Nov; 6(6):934-7. PubMed ID: 10548589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease.
    Clark SA; Martin SL; Pozniak A; Steel A; Ward B; Dunning J; Henderson DC; Nelson M; Gazzard B; Kelleher P
    Clin Exp Immunol; 2007 Nov; 150(2):238-44. PubMed ID: 17672869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised controlled trial of the effects of albendazole in pregnancy on maternal responses to mycobacterial antigens and infant responses to Bacille Calmette-Guérin (BCG) immunisation [ISRCTN32849447].
    Elliott AM; Namujju PB; Mawa PA; Quigley MA; Nampijja M; Nkurunziza PM; Belisle JT; Muwanga M; Whitworth JA;
    BMC Infect Dis; 2005 Dec; 5():115. PubMed ID: 16371154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversion and conversion of Mycobacterium tuberculosis IFN-gamma ELISpot results during anti-tuberculous treatment in HIV-infected children.
    Connell TG; Davies MA; Johannisen C; Wood K; Pienaar S; Wilkinson KA; Wilkinson RJ; Zar HJ; Beatty D; Nicol MP; Curtis N; Eley B
    BMC Infect Dis; 2010 May; 10():138. PubMed ID: 20507549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for increased immune reconstitution in response to Mycobacterium tuberculosis antigens in tuberculosis HIV-infected, antiretroviral-naïve patients.
    da Silva TP; Giacoia-Gripp CBW; Schmaltz CA; Sant'Anna FM; Saad MH; Matos JA; de Lima E Silva JCA; Rolla VC; Morgado MG
    BMC Infect Dis; 2017 Sep; 17(1):606. PubMed ID: 28874142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.